ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 700,08
0,49%
Dow Jones
39 112,16
-0,76%
DAX
18 355,31
1,06%
Brent Oil
84,395
0,25%
Bitcoin
61 554,33
-0,42%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ANI Pharmaceuticals Inc (ANIP)

  7. ANI Pharmaceuticals Inc (ANIP) Actualités

ANIP ANI Pharmaceuticals Inc

64,19
0,00 (0,00%)
26 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
ANI Pharmaceuticals Inc ANIP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 64,19 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
64,19
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/6/202413:00GLOBEANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY..
24/6/202412:50GLOBEANI Pharmaceuticals to Further Expand Rare Disease Business..
18/6/202422:37EDGAR2Form 144 - Report of proposed sale of securities
17/6/202423:05EDGAR2Form 144 - Report of proposed sale of securities
14/6/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202413:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202413:59EDGAR2Form 8-K - Current report
05/6/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:35EDGAR2Form 144 - Report of proposed sale of securities
29/5/202422:30GLOBEANI Pharmaceuticals to Present at the 2024 Jefferies Global..
24/5/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:06EDGAR2Form 8-K - Current report
23/5/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202422:57EDGAR2Form 144 - Report of proposed sale of securities
20/5/202412:50GLOBEANI Pharmaceuticals Announces the Launch of Kionex®..
18/5/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:50EDGAR2Form 144 - Report of proposed sale of securities
16/5/202423:02EDGAR2Form 144 - Report of proposed sale of securities
16/5/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:49EDGAR2Form 144 - Report of proposed sale of securities
15/5/202422:59EDGAR2Form 144 - Report of proposed sale of securities
15/5/202401:47EDGAR2Form 144 - Report of proposed sale of securities
14/5/202422:11EDGAR2Form 8-K - Current report
13/5/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202413:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202412:55EDGAR2Form 8-K - Current report
10/5/202412:50GLOBEANI Pharmaceuticals Reports Record First Quarter 2024..
01/5/202422:30GLOBEANI Pharmaceuticals to Participate at Two Upcoming..
18/4/202422:05GLOBEANI Pharmaceuticals to Discuss First Quarter 2024 Financial..
09/4/202412:50GLOBEANI Pharmaceuticals Announces the Launch of Baclofen Oral..
04/4/202412:50GLOBEANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month..
03/4/202412:50GLOBEANI Pharmaceuticals to Participate at the Piper Sandler..
27/3/202411:50GLOBEANI Pharmaceuticals Announces the Launch of Levofloxacin..
09/3/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:59EDGAR2Form 144 - Report of proposed sale of securities
08/3/202422:26EDGAR2Form 144 - Report of proposed sale of securities
08/3/202403:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 144 - Report of proposed sale of securities
06/3/202423:58EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
ANIP
ANI Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés